SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Nike shares are trading lower as the company hits a 12-year low. Continued weakness may be a result of sympathy with On Holding's recently reported Q2...
SanDisk Rips 10%, Micron Rises 6% as AI Memory Frenzy Builds: Stock Market Today...
CNBC Halftime Report Final Trades: Cisco Systems, Cheniere Energy, iShares U.S. Utilities ETF, Merck...
Chevron Makes Major Oil Discovery in Angola’s Offshore Block...
4 Health Care Stocks With Whale Alerts In Today’s Session...
Anthropic's Revenue Jumps 14x; Chinese AI Targets Nvidia's Moat...
Why Is Target Stock Falling on Monday?...
Caterpillar Launches $3M Workforce Initiative In Arkansas To Prepare Workers For Modern Manufacturing Careers...
The Slow-Motion Memecoin: Why Nike’s Multi-Year Unwind Is Taking So Long to Fix...
Home Depot Earnings Prediction Market Preview: Will CEO Ted Decker Talk About Tariffs?...
Home Depot Q2 Preview: Data Shows Visits Down, Will Earnings Say Otherwise?...
Home Depot Could Swing $14.6 Billion After Earnings...
Could Apple Stock Be Headed to $400?...
Nvidia Is the Best S&P 500 Stock of the Past 10, 15, 20 Years — but 4 Stocks Beat It Over the Past 5 Years...
QUICK SPARK: OpenAI, Anthropic and SpaceX Fuel Harbor’s New AI ETF Strategy Beyond Big Tech...
Here’s How Much You Would Have Made Owning JPMorgan Chase Stock In The Last 5 Years...
Jubilant Generics announced the FDA approval on August 17, 2026, for its abbreviated new drug application ANDA210592, marking a strategic expansion of...
Ray Dalio Champions 'Radical Transparency' in the Workplace, Says 'Important Issues Are Apparent Instead of Hidden'...
Apple's 'Ted Lasso' Breaks Records, Trump Thanks Tim Cook and More: This Week In Appleverse...
CoreWeave Jumped After Earnings, But Key Risks Could Derail Rally...